tiprankstipranks
Kezar Life Sciences Inc (DE:2KZ0)
FRANKFURT:2KZ0
Germany Market

Kezar Life Sciences (2KZ0) Income Statement

1 Followers

Kezar Life Sciences Income Statement

Last quarter (Q4 2025), Kezar Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kezar Life Sciences's net income was $-14.55M. See Kezar Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 7.00M$ 0.00$ 0.00
Gross Profit
$ -897.00K$ -1.04M$ 7.00M$ 0.00$ -1.51M
Operating Expenses
$ 51.37M$ 90.61M$ 118.42M$ 71.16M$ 53.15M
Depreciation and Amortization
$ 897.00K$ 1.04M$ 1.07M$ 1.02M$ 1.51M
EBITDA
$ -51.37M$ -81.10M$ -99.25M$ -66.03M$ -52.96M
Operating Income
$ -52.27M$ -90.61M$ -111.42M$ -71.16M$ -54.66M
Other Income/Expenses
$ -3.76M$ 6.87M$ 9.55M$ 2.92M$ 29.00K
Pretax Income
$ -56.03M$ -83.74M$ -101.87M$ -68.24M$ -54.63M
Net Income
$ -56.03M$ -83.74M$ -101.87M$ -68.24M$ -54.63M
Per Share Metrics
Basic EPS
$ -7.66$ -1.15$ -1.40$ -1.01$ -1.04
Diluted EPS
$ -7.66$ -1.15$ -1.40$ -1.01$ -1.04
Weighted Average Shares Outstanding
7.32M 72.90M 72.55M 67.37M 52.76M
Weighted Average Shares Outstanding (Diluted)
7.32M 72.90M 72.55M 67.37M 52.76M
Currency in USD

Kezar Life Sciences Earnings and Revenue History